Cargando…
Changes in hepatic fibrosis and vitamin D levels after viral hepatitis C eradication using direct-acting antiviral therapy
BACKGROUND: Vitamin D (VD) is important in hepatic fibrogenesis in animal models and human studies. VD deficiency is associated with liver fibrosis progression. Metabolic dysfunction of the liver, as an intermediate organ for VD metabolism, contributes partly to this deficiency. We hypothesized that...
Autores principales: | Sriphoosanaphan, Supachaya, Thanapirom, Kessarin, Suksawatamnuay, Sirinporn, Thaimai, Panarat, Sittisomwong, Sukanya, Sonsiri, Kanokwan, Srisoonthorn, Nunthiya, Teeratorn, Nicha, Tanpowpong, Nattaporn, Chaopathomkul, Bundit, Treeprasertsuk, Sombat, Poovorawan, Yong, Komolmit, Piyawat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7568415/ https://www.ncbi.nlm.nih.gov/pubmed/33069226 http://dx.doi.org/10.1186/s12876-020-01485-8 |
Ejemplares similares
-
Effect of vitamin D supplementation in patients with chronic hepatitis C after direct-acting antiviral treatment: a randomized, double-blind, placebo-controlled trial
por: Sriphoosanaphan, Supachaya, et al.
Publicado: (2021) -
Non-invasive tests for liver fibrosis assessment in patients with chronic liver diseases: a prospective study
por: Thanapirom, Kessarin, et al.
Publicado: (2022) -
Clinical significance of post-liver transplant hepatitis E seropositivity in high prevalence area of hepatitis E genotype 3: a prospective study
por: Komolmit, Piyawat, et al.
Publicado: (2020) -
Stability of hepatitis B virus pregenomic RNA in plasma specimens under various temperatures and storage conditions
por: Rattanachaisit, Pakkapon, et al.
Publicado: (2021) -
Assessment and validation of the TREAT-B score to assess the treatment eligibility of patients with chronic hepatitis B virus infection
por: Thanapirom, Kessarin, et al.
Publicado: (2022)